Binding assay of human Dectin-1 variants to DNA/β-glucan complex for active-targeting delivery of antisense DNA

Carbohydr Res. 2021 Feb:500:108219. doi: 10.1016/j.carres.2020.108219. Epub 2020 Dec 13.

Abstract

The lectin Dectin-1 is a good target for β-glucan-mediated drug delivery. Although many murine studies of Dectin-1 have been performed, its human analog has not been studied well in terms of being a drug delivery target. We thus analyzed human Dectin-1 cDNA obtained from chronic myelogenous leukemia-derived cells, CML-1, and confirmed the findings of previous studies that there are many isoforms of human Dectin-1 due to exon skipping, although murine Dectin-1 has only two forms. When we transfected the Dectin-1 gene into a non-Dectin-1-expressing cell line and examined cellular uptake of the antisense DNA/β-glucan complex, we confirmed that expression of the target gene was effectively suppressed through β-glucan/Dectin-1-mediated uptake. The present results suggest that the β-glucan complex would be an effective tool to deliver antisense oligonucleotide (AS-ODN) to Dectin-1-expressing cells not only for mice but also for humans.

Keywords: Active-targeting delivery; Antisense; Dectin-1; Immunocyte; Schizophyllan.

MeSH terms

  • Binding Sites
  • Carbohydrate Conformation
  • DNA / chemistry*
  • Drug Delivery Systems*
  • Humans
  • Lectins, C-Type / chemistry*
  • Oligonucleotides, Antisense / chemistry*
  • Tumor Cells, Cultured
  • beta-Glucans / chemistry*

Substances

  • CLEC7A protein, human
  • Lectins, C-Type
  • Oligonucleotides, Antisense
  • beta-Glucans
  • DNA